Sumatriptan Tablet
Product Images NDC 63187-323

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 63187-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A line graph depicting the estimated probability of response over time in minutes from initial dose, for placebo and three doses of Sumatriptan (25 mg, 50 mg, 100 mg). The y-axis shows response probability from 0% to 100%, and the x-axis shows time up to 240 minutes. The graph compares response rates between placebo and different dosage strengths over time.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A line graph depicting the estimated probability of remediation or rescue over 24 hours from initial dose for placebo and three doses of sumatriptan: 25 mg, 50 mg, and 100 mg. The x-axis shows time in hours, and the y-axis shows probability percentages from 0% to 100%. Four distinct curves represent each treatment, with placebo generally showing higher probabilities compared to the sumatriptan doses.*
FDA Label Image

63187-323-09 (Image 01)

63187-323-09 (Image 01)
Label for Sumatriptan 100 mg tablets, oral dosage form, relabeled by Proficient Rx LP. The label includes identification as prescription only (RX), description of the tablets as white to off-white, capsule-shaped, biconvex, uncoated with debossment "RB97" on one side. Product ID RS032309 and manufacturer information for Ranbaxy Pharmaceuticals Inc., Jacksonville, FL, are also shown.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of sumatriptan with its molecular components clearly shown as part of the representation for the active pharmaceutical ingredient sumatriptan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.